Juvenile absence epilepsy
ICD-10 G40.3 · ICD-11 8A61.31

Treatment of Juvenile Absence Epilepsy in Patients Aged 16 and Older

Juvenile absence epilepsy in adults aged 16 and older requires careful clinical management, with seizure control as the central goal. This protocol is structured for younger adults in this specific age group.

Clinical Scenario

This protocol applies to younger adults — specifically patients aged 16 years and older — diagnosed with juvenile absence epilepsy. Age-appropriate clinical considerations inform both treatment selection and outcome targets in this population.

Treatment Approach (Partial)

When seizures are not adequately controlled with antiepileptic drug therapy, this protocol outlines specific alternative approaches — both surgical and non-surgical — that may be appropriate for eligible patients. The complete clinical algorithm and selection criteria are in the full protocol.

Treatment Goal

Decreased frequency or elimination of seizures.

Instant Access to Structured Evidence-Based Regimens

References

Younger adults (16 to 59 years of age)

For patients with seizures that are not controlled with these agents, alternative treatments include surgical resection of the seizure focus, ketogenic diets, vagus nerve stimulators, and implantable brain neurostimulators.

The ketogenic diet, a high-fat, low-carbohydrate, and low-protein diet, induces ketone body formation.

Surgical resection of the seizure focus in appropriately selected patients often results in decreased frequency or elimination of seizures with improvement in quality of life.

View source ↗